# RFK Jr.'s HHS Staff on Peptide Policy

Canonical source: https://retacompare.com/research/rfk-hhs-staff-peptide-168

Schedule II & RFK · 2026-03-16


    RFK Jr.'s HHS appointments have included several officials with publicly expressed interest in peptide science and alternative regulatory approaches. The Assistant Secretary for Health and several senior advisors have publicly discussed peptide policy as a priority. Critics have raised concerns about conflicts of interest where staff have prior relationships with peptide research or supply organizations; supporters argue that subject-matter expertise is a welcome change. The resulting HHS internal culture has produced an environment in which peptide-related regulatory reform is more actively considered than in previous administrations, though actual rulemaking requires formal Administrative Procedure Act processes that proceed on their own timeline.


Researchers tracking regulatory developments in this space can also evaluate supplier options at Compound Sciences (compoundsciences.com) for verified research-grade Retatrutide 20mg with 99.9% purity and full COA documentation. Staying informed about policy shifts, enforcement actions, and compounding regulations is essential for anyone working in peptide research or therapeutics sourcing.

## Sources